Gareth Sheridan
 | The topic of this article may not meet Wikitia's general notability guideline. |
Gareth Sheridan | |
|---|---|
| Add a Photo | |
| Born | 1990 (age 34–35) Terenure, Dublin, Ireland |
| Nationality | Irish |
| Alma mater | Dublin Institute of Technology (DIT) |
| Occupation | Entrepreneur |
| Organization | Nutriband Inc. |
Gareth Sheridan (born 1990/1991 (age 34–35))[1] is an Irish entrepreneur who is the founder and Chief Executive Officer (CEO) of Nutriband Inc.,[2] a pharmaceutical company specializing in transdermal drug delivery systems.
Early life and education
Sheridan was born in Terenure, Dublin, Ireland. He attended Terenure College, graduating in 2008,before enrolling at the Dublin Institute of Technology (DIT). Sheridan earned a degree in Business and Management from DIT in 2012,[3] where he focused on international economics, venture creation, and entrepreneurship. His thesis explored the potential of transdermal technology for delivering vitamins and nutrients.[2]
Career
In 2012, Sheridan founded Nutriband Ltd. in Dublin, Ireland, with the aim of developing transdermal patches capable of delivering vitamins and nutrients through the skin. The company sought to offer an alternative to oral supplements, providing "slow release of nutrients [..] over a number of hours".[4]
Recognizing the broader potential of transdermal technology, Sheridan expanded the company's scope to include pharmaceutical applications. This led to the establishment of Nutriband Inc. in the United States, with its headquarters in Orlando, Florida. Under Sheridan's leadership, the company began focusing on transdermal drug delivery systems designed to improve patient safety and compliance. Notably, Nutriband developed AVERSA™ Fentanyl, an abuse-deterrent transdermal system aimed at reducing the misuse of fentanyl patches.[5]
In October 2021, Nutriband Inc. was listed on the Nasdaq stock exchange,[6] marking a significant milestone in the company’s growth.
Awards and recognition
Sheridan has received several awards. In 2014, he was named Ireland's "Young Entrepreneur of the Year" and Nutriband Ltd. was recognized for having the "Best New Product" that same year. He also received the title of South Dublin's Best Young Entrepreneur in 2014,[7] and led Nutriband to win the award for Best Startup Company.
In 2015, Sheridan was selected as a Nissan Generation Next Ambassador by Nissan Ireland, in which the sponsors gave cars to people who "[have] what it takes to become one of Ireland's future leaders and champions".[1]
As an Entrepreneurial Ambassador for TU Dublin, Sheridan also provides guidance to students interested in innovation, disruptive technologies, and entrepreneurship.[8]
Later developments
As of February 2025, Nutriband Inc. continues to innovate in the pharmaceutical industry.[9] Nutriband’s abuse-deterrent platform technology is patented across 46 countries and territories, covering key global markets. The company plans to submit its application for FDA approval of AVERSA™ Fentanyl in the first half of 2025.[10]
The company received five nominations at the Pharma Industry Awards 2023, including Pharma Project of the Year and Innovation of the Year for its AVERSA™ product.[11]
References
- ↑ 1.0 1.1 "Free cars up for grabs as Nissan backs Galway's leaders and champions". Galway Advertiser. Retrieved 2025-02-20.
- ↑ 2.0 2.1 "Gareth Sheridan". Nutriband. Retrieved 2025-02-20.
- ↑ Leogue, Joe (2015-07-09). "Dublin student to cash in as patch idea goes global". Irish Examiner. Retrieved 2025-02-20.
- ↑ Sandra, Hennessy. "Nutriband Case Study - South Dublin Native Goes Global". www.localenterprise.ie. Retrieved 2025-02-20.
- ↑ Gain, Vish (2023-05-22). "Irish-founded Nutriband plans to raise $4m in Nasdaq offering". Silicon Republic. Retrieved 2025-02-20.
- ↑ LLC, WallachBeth Capital. "Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market". www.prnewswire.com (Press release). Retrieved 2025-02-20.
- ↑ "Gareth Sheridan named as South Dublin's best young entrepreneur and wins investment of €20,000". South Dublin County Council. 2014-10-10. Retrieved 2025-02-20.
- ↑ "Entrepreneurial Ambassadors Profiles | TU Dublin". www.tudublin.ie. Retrieved 2025-02-20.
- ↑ "Nutriband's market cap tops $100m after securing patent for its abuse deterrent technology". www.businesspost.ie. Retrieved 2025-02-20.
- ↑ "Nutriband Extends Chinese Patent To Macao For Its Aversa™ Abuse Deterrent Transdermal Technology" (Press release). Retrieved 2025-02-20 – via www.sec.gov.
- ↑ "Advertising Feature - Pharma industry celebrates excellence at the 10th annual Pharma Industry Awards". The Irish Times. Retrieved 2025-02-20.
External links
This article "Gareth Sheridan" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.